project id: TCGA-UCEC; case submitter id: TCGA-2E-A9G8; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.44; rna integrity number: 7.7; age at index: 59; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1952; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1249.0; figo stage: Stage III; icd 10 code: C54.3; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Fundus uteri; synchronous malignancy: Not Reported; tissue or organ of origin: Fundus uteri; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 957; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-2E-A9G8-01A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;